Arcadia Biosciences (NASDAQ: RKDA) reported Q3 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $1.08 million versus the consensus estimate of $2.1 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.